Reliability of large language model knowledge across brand and generic cancer drug names
Jack Gallifant, Shan Chen, Sandeep K. Jain, Pedro Moreira, Umit Topaloglu, Hugo JWL Aerts, Jeremy L. Warner, William G. La Cava, Danielle S. Bitterman
doi: https://doi.org/10.1101/2024.11.08.24316949
Jack Gallifant
1Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA
2Department of Radiation Oncology, Brigham and Women’s Hospital/Dana-Farber Cancer Institute, Boston, MA, USA
MBBSShan Chen
1Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA
2Department of Radiation Oncology, Brigham and Women’s Hospital/Dana-Farber Cancer Institute, Boston, MA, USA
3Computational Health Informatics Program, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA
MSSandeep K. Jain
4Center for Clinical Cancer Informatics and Data Science, Legorreta Cancer Center, Brown University, Providence, RI, USA
5Rhode Island Hospital, Providence, RI, USA
MDPedro Moreira
6Universitat Pompeu Fabra, Barcelona, Spain
Umit Topaloglu
7Informatics and Data Science Program, National Cancer Institute, Rockville, MD, USA
Hugo JWL Aerts
1Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA
2Department of Radiation Oncology, Brigham and Women’s Hospital/Dana-Farber Cancer Institute, Boston, MA, USA
8Radiology and Nuclear Medicine, GROW & CARIM Maastricht University, Maastricht, Netherlands
PhDJeremy L. Warner
4Center for Clinical Cancer Informatics and Data Science, Legorreta Cancer Center, Brown University, Providence, RI, USA
5Rhode Island Hospital, Providence, RI, USA
9Medicine and Biostatistics, Brown University, Providence, RI, USA
MDWilliam G. La Cava
3Computational Health Informatics Program, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA
PhDDanielle S. Bitterman
1Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA
2Department of Radiation Oncology, Brigham and Women’s Hospital/Dana-Farber Cancer Institute, Boston, MA, USA
3Computational Health Informatics Program, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA
MD
Data Availability
The full code and dataset are available in our public repository at BittermanLab/OncoRABBITS.
Posted November 08, 2024.
Reliability of large language model knowledge across brand and generic cancer drug names
Jack Gallifant, Shan Chen, Sandeep K. Jain, Pedro Moreira, Umit Topaloglu, Hugo JWL Aerts, Jeremy L. Warner, William G. La Cava, Danielle S. Bitterman
medRxiv 2024.11.08.24316949; doi: https://doi.org/10.1101/2024.11.08.24316949
Reliability of large language model knowledge across brand and generic cancer drug names
Jack Gallifant, Shan Chen, Sandeep K. Jain, Pedro Moreira, Umit Topaloglu, Hugo JWL Aerts, Jeremy L. Warner, William G. La Cava, Danielle S. Bitterman
medRxiv 2024.11.08.24316949; doi: https://doi.org/10.1101/2024.11.08.24316949
Subject Area
Subject Areas
- Addiction Medicine (407)
- Allergy and Immunology (718)
- Anesthesia (212)
- Cardiovascular Medicine (3024)
- Dermatology (256)
- Emergency Medicine (451)
- Epidemiology (12935)
- Forensic Medicine (12)
- Gastroenterology (844)
- Genetic and Genomic Medicine (4737)
- Geriatric Medicine (437)
- Health Economics (744)
- Health Informatics (3002)
- Health Policy (1087)
- Hematology (404)
- HIV/AIDS (950)
- Medical Education (447)
- Medical Ethics (117)
- Nephrology (484)
- Neurology (4521)
- Nursing (241)
- Nutrition (666)
- Oncology (2346)
- Ophthalmology (664)
- Orthopedics (262)
- Otolaryngology (332)
- Pain Medicine (294)
- Palliative Medicine (85)
- Pathology (510)
- Pediatrics (1224)
- Primary Care Research (513)
- Public and Global Health (7110)
- Radiology and Imaging (1577)
- Respiratory Medicine (936)
- Rheumatology (455)
- Sports Medicine (393)
- Surgery (501)
- Toxicology (63)
- Transplantation (215)
- Urology (187)